OncoMatch/Clinical Trials/NCT07400224

Clinical Application of Al18F-NOTA-FAPI-04 PET/CT or PET/MRI Imaging in Malignant Tumor,Cardiovascular or Immune Disease

Is NCT07400224 recruiting? Yes, currently enrolling (Jun 2026). This Phase 1/2 trial studies non-drug interventions for hyperthyroidism, autoimmune.

Phase 1/2RecruitingPeking Union Medical College HospitalNCT07400224Data as of Jun 2026Location: China

This prospective, single-center study investigates the biodistribution, dosimetry, safety, diagnostic performance of Al18F-NOTA-FAPI PET imaging in patients with malignant tumor,cardiovascular or immune disease. And evaluates the potential of Al18F-NOTA-FAPI PET imaging in Clinical treatment strategy guidance.

Check if I qualify

Extracted eligibility criteria

Cancer type

Tumor Agnostic

Demographics

Ages ≤ 88

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Frequently asked questions

Is NCT07400224 currently recruiting?

Yes, this trial is currently recruiting patients.

Is there an age limit?

Yes. Patients must be 88 years or younger.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify